Sign Up Today and Learn More About Star Therapeutics Stock
Invest in or calculate the value of your shares in Star Therapeutics or other pre-IPO companies through EquityZen's platform.
![Star Therapeutics](https://dioguwdgf472v.cloudfront.net/media/logos/equityinvest/Company/startherapeutics_logo-9ce264faa82ed384.png)
Star Therapeutics Stock
Star Therapeutics mission is to develop therapies for as many diseases as possible for millions of patients.
About Star Therapeutics Stock
Founded
2018
Headquarters
South San Francisco, CA, US
Industries
Software, Data and Analytics, Artificial Intelligence
Star Therapeutics Press Mentions
Stay in the know about the latest news on Star Therapeutics
Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer and Chief Financial Officer
businesswire • Jan 03, 2024
Star Therapeutics welcomes Matthew Fust to its Board as Independent Director
talent4boards • Dec 14, 2023
Star Therapeutics’ $90 Million Series C Financing Round
globallegalchronicle • Sep 14, 2023
The Week’s 10 Biggest Funding Rounds: Stack AV And Ascend Elements Lead Another Huge Week
news • Sep 08, 2023
Star Therapeutics Lands $90M to Expand Its Drug Discovery Universe
medcitynews • Sep 06, 2023
Star Therapeutics Management
Leadership team at Star Therapeutics
Board Observer
Amrit Nagpal
Board Member
Carl L. Gordon
![Locked Features](https://dioguwdgf472v.cloudfront.net/assets/equityzen/img/public-company/locked-features.png)
Join now and verify your accreditation status to gain access to:
- Star Therapeutics current valuation
- Star Therapeutics stock price
- Available deals in Star Therapeutics and all other companies
- Deal offering documents
- EquityZen's proprietary data and insights, including
- Cap tables, which include funding history by Share Class and Liquidity Preferences
- Company Highlights
- Business Model
- Risk Factors
How to invest in Star Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Star Therapeutics through EquityZen funds. These investments are made available by existing Star Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Star Therapeutics stock?
Shareholders can sell their Star Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 310K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 42K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."